These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

201 related items for PubMed ID: 19708978

  • 1. Guanidino compounds as uremic (neuro)toxins.
    De Deyn PP, Vanholder R, Eloot S, Glorieux G.
    Semin Dial; 2009; 22(4):340-5. PubMed ID: 19708978
    [Abstract] [Full Text] [Related]

  • 2. Endogenous guanidino compounds as uremic neurotoxins.
    De Deyn PP, D'Hooge R, Van Bogaert PP, Marescau B.
    Kidney Int Suppl; 2001 Feb; 78():S77-83. PubMed ID: 11168988
    [Abstract] [Full Text] [Related]

  • 3. Guanidino compounds that are increased in cerebrospinal fluid and brain of uremic patients inhibit GABA and glycine responses on mouse neurons in cell culture.
    De Deyn PP, Macdonald RL.
    Ann Neurol; 1990 Nov; 28(5):627-33. PubMed ID: 2135950
    [Abstract] [Full Text] [Related]

  • 4. Nitric oxide in uremia: effects of several potentially toxic guanidino compounds.
    De Deyn PP, Vanholder R, D'Hooge R.
    Kidney Int Suppl; 2003 May; (84):S25-8. PubMed ID: 12694302
    [Abstract] [Full Text] [Related]

  • 5. Guanidino compound levels in brain regions of non-dialyzed uremic patients.
    De Deyn PP, Marescau B, D'Hooge R, Possemiers I, Nagler J, Mahler C.
    Neurochem Int; 1995 Sep; 27(3):227-37. PubMed ID: 8520461
    [Abstract] [Full Text] [Related]

  • 6. Convulsive action and toxicity of uremic guanidino compounds: behavioral assessment and relation to brain concentration in adult mice.
    D'Hooge R, Pei YQ, Marescau B, De Deyn PP.
    J Neurol Sci; 1992 Oct; 112(1-2):96-105. PubMed ID: 1469446
    [Abstract] [Full Text] [Related]

  • 7. [Platelet aggregation in chronic renal failure--whole blood aggregation and effect of guanidino compounds].
    Maejima M, Takahashi S, Hatano M.
    Nihon Jinzo Gakkai Shi; 1991 Feb; 33(2):201-12. PubMed ID: 2051648
    [Abstract] [Full Text] [Related]

  • 8. Factors affecting serum and urinary guanidinosuccinic acid levels in normal and uremic subjects.
    Kopple JD, Gordon SI, Wang M, Swendseid ME.
    J Lab Clin Med; 1977 Aug; 90(2):303-11. PubMed ID: 886215
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. GSA: behavioral, histological, electrophysiological and neurochemical effects.
    Torremans A, Marescau B, Van Dam D, Van Ginneken C, Van Meir F, Van Bogaert PP, D'Hooge R, de Vente J, De Deyn PP.
    Physiol Behav; 2005 Feb 15; 84(2):251-64. PubMed ID: 15708777
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L.
    Dan Med Bull; 2008 Nov 15; 55(4):186-210. PubMed ID: 19232159
    [Abstract] [Full Text] [Related]

  • 14. [Clinical and metabolic consequences of uremic toxicity].
    Rutkowski P.
    Przegl Lek; 2006 Nov 15; 63(4):209-17. PubMed ID: 17080744
    [Abstract] [Full Text] [Related]

  • 15. Inhibition of transepithelial sodium transport in the frog skin by a low molecular weight fraction of uremic serum.
    Bourgoignie J, Klahr S, Bricker NS.
    J Clin Invest; 1971 Feb 15; 50(2):303-11. PubMed ID: 5540168
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Guanidino compounds as cause of cardiovascular damage in chronic kidney disease: an in vitro evaluation.
    Schepers E, Glorieux G, Dou L, Cerini C, Gayrard N, Louvet L, Maugard C, Preus P, Rodriguez-Ortiz M, Argiles A, Brunet P, Cohen G, Jankowski J, Jankowski V, Massy Z, Rodriguez M, Vanholder R, European Uremic Toxin Work Group (EUTox).
    Blood Purif; 2010 Feb 15; 30(4):277-87. PubMed ID: 21079396
    [Abstract] [Full Text] [Related]

  • 19. Uraemic guanidino compounds inhibit gamma-aminobutyric acid-evoked whole cell currents in mouse spinal cord neurones.
    D'Hooge R, De Deyn PP, Van de Vijver G, Antoons G, Raes A, Van Bogaert PP.
    Neurosci Lett; 1999 Apr 16; 265(2):83-6. PubMed ID: 10327174
    [Abstract] [Full Text] [Related]

  • 20. Cationic uremic toxins affect human renal proximal tubule cell functioning through interaction with the organic cation transporter.
    Schophuizen CM, Wilmer MJ, Jansen J, Gustavsson L, Hilgendorf C, Hoenderop JG, van den Heuvel LP, Masereeuw R.
    Pflugers Arch; 2013 Dec 16; 465(12):1701-14. PubMed ID: 23812163
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.